Berkshire Bank Bristol Myers Squibb CO Transaction History
Berkshire Bank
- $403 Million
- Q1 2025
A detailed history of Berkshire Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Berkshire Bank holds 9,951 shares of BMY stock, worth $466,204. This represents 0.15% of its overall portfolio holdings.
Number of Shares
9,951
Previous 10,235
2.77%
Holding current value
$466,204
Previous $578,000
4.84%
% of portfolio
0.15%
Previous 0.14%
Shares
19 transactions
Others Institutions Holding BMY
# of Institutions
2,806Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$8.97 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.06 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.44 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.11 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.6B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...